An affordable price is probably the major benefit persuading people to buy drugs at www.americanbestpills.com. The cost of medications in Canadian drugstores is considerably lower than anywhere else simply because the medications here are oriented on international customers. In many cases, you will be able to cut your costs to a great extent and probably even save up a big fortune on your prescription drugs. What's more, pharmacies of Canada offer free-of-charge shipping, which is a convenient addition to all other benefits on offer. Cheap price is especially appealing to those users who are tight on a budget
Service Quality and Reputation Although some believe that buying online is buying a pig in the poke, it is not. Canadian online pharmacies are excellent sources of information and are open for discussions. There one can read tons of users' feedback, where they share their experience of using a particular pharmacy, say what they like or do not like about the drugs and/or service. Reputable online pharmacy canadianrxon.com take this feedback into consideration and rely on it as a kind of expert advice, which helps them constantly improve they service and ensure that their clients buy safe and effective drugs. Last, but not least is their striving to attract professional doctors. As a result, users can directly contact a qualified doctor and ask whatever questions they have about a particular drug. Most likely, a doctor will ask several questions about the condition, for which the drug is going to be used. Based on this information, he or she will advise to use or not to use this medication.

A Deeper Dive on the World Health Organization

Hold on…it is gonna be a rough ride….President Trump must not only investigate but for sure suspend funding….the reasons go way beyond the recent scandalous headlines.

Given the tight relationship between Dr. Tedros Adhanom, the Director and the Chinese Communist Party, it is a certainty that WHO is in possession of the report noted below:

Chinese researchers initially pointed to the possibility of a lab accident in a study published in February on ResearchGate. “The killer coronavirus probably originated from a laboratory in Wuhan,” wrote researchers — although they also raised the possibility of natural transmission. “Safety level may need to be reinforced in high risk biohazardous laboratories,” continued Botao Xiao and Lei Xiao of Guangxhou’s South China University of Technology.

and then there is this –> The possibility that the virus leaked during a lab accident “is being seriously considered” within the U.S. government, according to another recently retired senior national security official, who pointed to the State Department’s 2019 compliance report on arms control, nonproliferation and disarmament. The report notes that Chinese officials have failed to reassure inspectors they are obeying the Biological Weapons Convention, including by not providing information about research on “numerous toxins with potential dual-use application.”  More here.

From my friend Adam Andrzejewski with his Forbes piece on funding the WHO…the money that flowed in recent years to WHO is remarkable.

With his recent vow to halt and reassess all aid to the World Health Organization (WHO), President Trump legitimized critics who allege that the agency shielded information from the world about the lethality of the coronavirus and its ability to spread by human-to-human contact.

The WHO delegation highly appreciated the actions China has implemented in response to the outbreak, its speed in identifying the virus and openness to sharing information with WHO and other countries.

World Health Organization | January 28, 2020 | Beijing

The most likely presidential policy response will be to re-purpose all or most federal money from the WHO. If done in this manner, the president must notify Congress, but has the executive power to reallocate the monies to other organizations. Therefore, legitimate programs will continue to help humanity.

Responding to our request for comment, the White House, Office of Management and Budget provided a fact sheet detailing the WHO’s “corruption and abuse.”

The W.H.O. really blew it. We will be giving that a good look.

President Donald J. Trump
Our auditors at OpenTheBooks.com reviewed all disclosed grants by federal agencies to the WHO since 2010 and found that $3.5 billion in taxpayer money funded the WHO during this period.

What’s more, only $611.1 million of that funding came from “assessed dues” required by participating countries. The U.S. government voluntarily sent the WHO roughly $2.9 billion more than their required contribution. It’s no surprise that, annually, the United States is the largest funder of the WHO.

We also found that federal funding of the WHO remained strong during the Trump era. We compared the first three years of the Trump administration (FY2017-FY2019) to the first three years during the second term of President Barack Obama’s administration (FY2013-FY2015).

The WHO received more money under Trump than Obama (inflation adjusted): $1.4 billion versus $1.1 billion.

Since 2010, the Agency for International Development (USAID) has led all federal agencies with $1.5 billion in grants to the WHO. Roughly half the USAID grant money funded three programs: humanitarian programs ($345.7 million); polio eradication efforts ($307.8 million); and efforts to eliminate tuberculosis ($116.6 million).

Other programs include efforts in Iraq, Afghanistan, Yemen, Libya, Sri Lanka, Sudan, and Pakistan and included gender-based anti-violence initiatives; life-saving healthcare services to vulnerable populations; and assistance in floods, emergencies, and to war-torn communities.

USAID efforts through the WHO and other international humanitarian aid agencies were singled out in a blistering USAID Inspector General report in 2018, Insufficient Oversight of Public International Organizations Puts U.S. Foreign Assistance Programs at Risk.

As of January 2018, Office of Inspector General (OIG) investigations in the region have resulted in the suspension or debarment of several dozen individuals and organizations, 20 personnel actions, and the suspension of $239 million in program funds under investigation.

USAID Office of Inspector General

The U.S. Department of State gave $820 million to the WHO since 2010. The largest portion of the money consisted of “assessments” or dues to the organization which amounted to $611.1 million. In addition, the State Department funded programs for “general assistance” ($95 million); “refugee” health ($17.3 million); “peacekeeping” ($15.9 million); and emergency vaccines ($2 million).

Here’s an overview of programs funded by other U.S. federal agencies such as the Centers for Disease Control (CDC) ($1 billion), Food and Drug Administration (FDA) ($30 million), National Institutes of Health (NIH) ($13.5 million), Department of Defense ($10 million) and the Environmental Protection Agency ($3.2 million) at the WHO since 2010:

  • Immunizations, Research, Demonstration, and Public Education/Information: $524.1 million — Through the Department of Health and Human Services and Centers for Disease Control, this funding was spent on WHO programs for the eradication of polio around the world. These grants were centralized through WHO headquarters in Geneva, Switzerland.
  • Global AIDS: $134.8 million — The Department of Health and Human Services and the Centers for Disease control funded support services and the strengthening of public health guidelines around the world to mitigate global AIDS.
  • Ebola virus: $73.5 million — In July 2019 and January 2020, the Congo received $15 million in Ebola eradication grants from the Trump administration specifically earmarked for the provinces of North Kivu and Ituri. The rest of the funding flowed through WHO headquarters in Geneva, Switzerland, with the majority of the funding between the fiscal years 2015 and 2017.
  • Biomedical research: $37.9 million — The National Institutes for Health (NIH) collaborated with the WHO on biomedical research. These programs included research on allergies, infectious diseases, and immunology. The transactions show that most funding was for “accelerated public health and biomedical research in priority public health objectives.”

The coronavirus pandemic is testing the World Health Organization. Just like any other health care body, every aspect of their operation will receive scrutiny during these times of insecurity and crisis.

Our analysis of WHO funding by U.S. federal agencies shows that taxpayers have been generous and deserve to know how their money is being spent.

Until recently, American commitments remained strong.

Note: All federal government funded delineated in this piece was disclosed through the Federal Funding Accountability and Transparency Act of 2006, co-sponsors Sens. Tom Coburn (R-OK) and Barack Obama (D-IL). (Public Law 109-282, 109th Congress)

Then there is the matter of the CDC…we will cover that another time.

2017, U.S. Knew the Safety Risks of the Wuhan Virology Lab

But it gets much worse….so we will begin with the diplomatic cables…

A woman wearing a protective suit at a hospital in Wuhan, China.
A woman wearing a protective suit at a hospital in Wuhan, China. (Aly Song/Reuters)
April 14, 2020

Two years before the novel coronavirus pandemic upended the world, U.S. Embassy officials visited a Chinese research facility in the city of Wuhan several times and sent two official warnings back to Washington about inadequate safety at the lab, which was conducting risky studies on coronaviruses from bats. The cables have fueled discussions inside the U.S. government about whether this or another Wuhan lab was the source of the virus — even though conclusive proof has yet to emerge.

In January 2018, the U.S. Embassy in Beijing took the unusual step of repeatedly sending U.S. science diplomats to the Wuhan Institute of Virology (WIV), which had in 2015 become China’s first laboratory to achieve the highest level of international bioresearch safety (known as BSL-4). WIV issued a news release in English about the last of these visits, which occurred on March 27, 2018. The U.S. delegation was led by Jamison Fouss, the consul general in Wuhan, and Rick Switzer, the embassy’s counselor of environment, science, technology and health. Last week, WIV erased that statement from its website, though it remains archived on the Internet.

What the U.S. officials learned during their visits concerned them so much that they dispatched two diplomatic cables categorized as Sensitive But Unclassified back to Washington. The cables warned about safety and management weaknesses at the WIV lab and proposed more attention and help. The first cable, which I obtained, also warns that the lab’s work on bat coronaviruses and their potential human transmission represented a risk of a new SARS-like pandemic. More here.

Now, exactly why would a U.S. delegation visit the Wuhan laboratory in the first place and be granted permission to do so?

Experts in the field of virology have been collaborating on research related to viruses in China for years. This includes government health officials, university research/medical schools as well as scientists and laboratory technicians. Last month, I published an article about the collaboration between various health/virus experts and the P4 laboratory in question located in Wuhan, using Duke NUS Medical School as but one example.

But, there is another reason for U.S. access and that is the U.S, government gave a sizeable grant to the Wuhan laboratory at the center of the pandemic. Yes, a mere $3.7 MILLION. Likely, the most experienced scientist at this facility is Shi Zhengli. She is honest, candid and desperate. She gladly works with organizations outside of China and even asked for more U.S. help with security measures and control of the facility.

Biosafety Level 4 Laboratory, Wuhan Institute of Virology. The institute is at the center of several controversial conspiracy theories that claim it is to blame for the coronavirus outbreak

Hold on….here is the backstory

The Chinese laboratory at the center of scrutiny over a potential coronavirus leak has been using U.S. government money to carry out research on bats from the caves which scientists believe are the original source of the deadly outbreak.

The Wuhan Institute of Virology undertook coronavirus experiments on mammals captured more than 1,000 miles away in Yunnan which were funded by a $3.7 million grant from the US government.

Sequencing of the COVID-19 genome has traced it back to bats found in Yunnan caves but it was first thought to have transferred to humans at an animal market in Wuhan.

The revelation that the Wuhan Institute was experimenting on bats from the area already known to be the source of COVID-19 – and doing so with American money – has sparked further fears that the lab, and not the market, is the original outbreak source.

Lawmakers and pressure groups were quick to hit out at U.S. funding being provided for the ‘dangerous and cruel animal experiments at the Wuhan Institute’.

US Congressman Matt Gaetz said: ‘I’m disgusted to learn that for years the US government has been funding dangerous and cruel animal experiments at the Wuhan Institute, which may have contributed to the global spread of coronavirus, and research at other labs in China that have virtually no oversight from US authorities.’

On Saturday, Anthony Bellotti, president of the US pressure group White Coat Waste, condemned his government for spending tax dollars in China, adding: ‘Animals infected with viruses or otherwise sickened and abused in Chinese labs reportedly may be sold to wet markets for consumption once experiments are done.’

The $37million Wuhan Institute of Virology, the most advanced laboratory of its type on the Chinese mainland, is based twenty miles from the now infamous wildlife market that was thought to be the location of the original transfer of the virus from animals to humans.

According to documents obtained by The Mail on Sunday, scientists there experimented on bats as part of a project funded by the US National Institutes of Health, which continues to licence the Wuhan laboratory to receive American money for experiments.

The NIH is the primary agency of the United States government responsible for biomedical and public health research.

The Wuhan Institute lists them on their website as a partner as well as several other American academic institutions.

Other U.S. partners include the University of Alabama, the University of North Texas, Harvard University, and the National Wildlife Federation.

As part of the NIH research at the institute, scientists grew a coronavirus in a lab and injected it into three-day-old piglets.

The news that COVID-19 bats were under research there means that a leak from the Wuhan laboratory can no longer be completely ruled out.

According to one unverified claim, scientists at the institute could have become infected after being sprayed with blood containing the virus, and then passed it on to the local community.

A second institute in the city, the Wuhan Centre for Disease Control – which is barely three miles from the market – is also believed to have carried out experiments on animals such as bats to examine the transmission of coronaviruses.

The Wuhan Institute, which keeps more than 1,500 strains of deadly viruses, specializes in the research of ‘the most dangerous pathogens’, in particular the viruses carried by bats.

Chinese officials decided to build the institute after the country was ravaged by an outbreak of SARS in 2002 and 2003.

SARS, another kind of coronavirus, killed 775 people and infected more than 8,000 globally in an epidemic.

Since an outbreak of the novel coronavirus emerged in the city in December, it has been at the center of conspiracy theories which suggest that the bug originated there.

While scientists believe that the virus jumped to humans from wild animals sold as food in a market in Wuhan, conspiracy theorists promote different assumptions.

Some of them claim that the virus, formally known as SARS-CoV-2, could be a biological warfare weapon engineered there. Others suspect that it escaped from the lab.

China has repeatedly denied the allegations.

Shi Zhengli, a deputy director of the institute, told the press in February that she ‘guaranteed with her own life’ that the outbreak was not related to the lab.

She admits that when summoned back from a conference to investigate the new disease, she wondered at first if a coronavirus could have escaped from her unit.

She has warned about the danger of epidemics from bat-borne viruses.

But she says she did not expect such an outbreak in Wuhan, in the center of China, since her studies suggested subtropical areas in the south had the highest risk of such ‘zoonotic’ transmission to humans.

Shi told the respected science journal Scientific American last month of her relief when, having checked back through disposal records, none of the genome sequences matched their virus samples.

‘That really took a load off my mind. I had not slept a wink for days,’ she said.

Many international experts have also dismissed such theories.

Dr Keusch, Professor of Medicine and International Health at Boston University’s Schools of Medicine and Public Health, stressed that no release of viruses from a high-level lab, such as the one in Wuhan, ‘has ever happened’.

He defended his peers in the Chinese city as he said: ‘The Wuhan lab is designed to the highest standards with redundant safety systems and the highest level of training.

‘Many of its research faculty trained at a similar laboratory in Galveston, Texas. So we know the Wuhan team is as qualified as the Texas group…

‘This means the assertion of a leak, rather than being highly likely, instead is highly unlikely.’

Last week, further doubt was cast on the animal market theory, however, after Cao Bin, a doctor at the Wuhan Jinyintan Hospital, highlighted research showing that 13 of the first 41 patients diagnosed with the infection had not had any contact with the market.

‘It seems clear that the seafood market is not the only origin of the virus,’ he said.

American biosecurity expert Professor Richard Ebright, of Rutgers University’s Waksman Institute of Microbiology, New Jersey, said that while the evidence suggests COVID-19 was not created in one of the Wuhan laboratories, it could easily have escaped from there while it was being analyzed.

Prof Ebright said he has seen evidence that scientists at the Centre for Disease Control and the Institute of Virology studied the viruses with only ‘level 2’ security – rather than the recommended level 4 – which ‘provides only minimal protections against infection of lab workers’.

He added: ‘Virus collection, culture, isolation, or animal infection would pose a substantial risk of infection of a lab worker, and from the lab worker then the public.’

He concluded that the evidence left ‘a basis to rule out [that coronavirus is] a lab construct, but no basis to rule out a lab accident’.

Results of the U.S-funded research at the Wuhan Institute were published in November 2017 under the heading: ‘Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.’

The exercise was summarized as: ‘Bats in a cave in Yunnan, China were captured and sampled for coronaviruses used for lab experiments.

‘All sampling procedures were performed by veterinarians with approval from the Animal Ethics Committee of the Wuhan Institute of Virology.

‘Bat samplings were conducted ten times from April 2011 to October 2015 at different seasons in their natural habitat at a single location (cave) in Kunming, Yunnan Province, China. Bats were trapped and faecal swab samples were collected.’

Another study, published in April 2018, was titled ‘fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin’ and described the research as such: ‘Following a 2016 bat-related coronavirus outbreak on Chinese pig farms, bats were captured in a cave and samples were taken.

Experimenters grew the virus in a lab and injected it into three-day-old piglets.

Intestinal samples from sick piglets were ground up and fed to other piglets as well.

The coronavirus pandemic has killed more than 108,000 people and infected over 1.7 million worldwide.’

On Saturday, the American outbreak became the deadliest in the world over 2,000 deaths in a day.

The national deaths toll is 20,087 and there are 522,643 confirmed cases as of Saturday evening.

China muzzled its Bat Woman: Beijing authorities hushed up the findings of a scientist who unlocked the genetic make-up of the coronavirus within days of the outbreak – which is vital for tests and vaccines

 A Chinese scientist who is the one of the world’s leading experts on coronaviruses was ‘muzzled’ after unraveling the genetic composition of the new disease, which is crucial for developing diagnostic tests and vaccines.

The revelation will fuel fresh concerns over China‘s cover-up of the pandemic after it erupted in the city of Wuhan. Critics argue that Communist Party chiefs frustrated efforts to contain the outbreak before it exploded around the world.

At the centre of the new claims is Shi Zhengli, known as China’s ‘Bat Woman’ after years spent on difficult virus-hunting expeditions in dank caves that have led to a series of important scientific discoveries.

The virologist was called back to her highsecurity laboratory in Wuhan at the end of last year after a mysterious new respiratory condition in the city was identified as a novel coronavirus – and within three days she completed its gene sequencing.

Her team’s work, and several other breakthroughs in subsequent days, indicated the virus was linked to horseshoe bats found more than 1,000 miles away in Yunnan, a region of southern China.

Their findings showed it was similar to SARS, a respiratory disease that sparked an epidemic in 33 countries after emerging from China in 2002.

Gao Yu, a Chinese journalist freed last week after 76 days of lockdown in Wuhan, said he spoke to Shi during his incarceration and revealed: ‘We learned later her institute finished gene-sequencing and related tests as early as January 2 but was muzzled.’

The Mail on Sunday has learned that on that same day, Yanyi Wang, director of the Wuhan Institute of Virology, sent an email to staff and key officials ordering them not to disclose information on the disease.

She warned, according to a leak on social media confirmed by activists and Hong Kong media, that ‘inappropriate and inaccurate information’was causing ‘general panic’ – thought to refer to eight whistle-blowing doctors whose warnings to local citizens had led to their arrest.

Wang said the National Health Commission ‘unequivocally requires that any tests, clinical data, test results, conclusions related to the epidemic shall not be posted on social media platforms, nor shall [it] be disclosed to any media outlets including government official media, nor shall [it] be disclosed to partner institutions.’

Eight days later, a team led by a professor in Shanghai who received samples from an infected patient, published a genome sequence on an open access platform.

His laboratory was closed for ‘rectification’ two days later.

At the time, the public was being told that no new cases had been reported in Wuhan for more than a week and there was no clear evidence of human transmission, although dozens of health workers were starting to fall ill with the disease.

In an online lecture last month, Shi Zhengli said her team found on January 14 that the new virus could infect people – six days before this fact was revealed by China.

On the same day, the World Health Organisation issued a tweet backing China’s denials of human transmissions.

Shi’s team released its data identifying the disease on January 23 on a scientific portal before publication the next month by the journal Nature.

It said the genomic sequence was 96 per cent identical to another virus they found in horseshoe bats in Yunnan.

Shi is a specialist in emerging diseases and has earned global acclaim for work investigating links between bats and coronaviruses, aided by expeditions to collect samples and swabs in the fetid cave networks of southern China.

She was a key part of the team that traced SARS to horseshoe bats through civets, a cat-like creature often eaten in China.

Hat tip –> By Frances Mulraney and Glenn Owen For The Mail On Sunday

 

 

 

 

The Reason for the WH and Dr. Birx Chilling New Probability Report

Primer: We all seem to guess this except for Jim Acosta/CNN and the others at MSNBC. Media continues to blame the Trump White House for the slow response to address COVID-19, while Dr. Birx and Dr. Fauci explained what they did not know very early on. Now we know.

Now some real questions and new policy towards China must be considered. We can start with the $1.8 T in U.S. debt that China holds. The next is challenging American telecommunications companies to squelch China’s advances of 5G. Then there is the next phase of the U.S. trade agreement with China. Add in the mission to stop China’s power agenda across the globe as it is clear, China is fine with killing people and economies across the world.

China has concealed the extent of the coronavirus outbreak in its country, under-reporting both total cases and deaths it’s suffered from the disease, the U.S. intelligence community concluded in a classified report to the White House, according to three U.S. officials.

The officials asked not to be identified because the report is secret and declined to detail its contents. But the thrust, they said, is that China’s public reporting on cases and deaths is intentionally incomplete. Two of the officials said the report concludes that China’s numbers are fake.

The report was received by the White House last week, one of the officials said. The outbreak began in China’s Hubei province in late 2019, but the country has publicly reported only about 82,000 cases and 3,300 deaths, according to data compiled by Johns Hopkins University. That compares to more than 189,000 cases and more than 4,000 deaths in the U.S., which has the largest publicly reported outbreak in the world.

Communications staff at the White House and Chinese embassy in Washington didn’t immediately respond to requests for comment.

While China eventually imposed a strict lockdown beyond those of less autocratic nations, there has been considerable skepticism of China’s reported numbers, both outside and within the country. The Chinese government has repeatedly revised its methodology for counting cases, for weeks excluding people without symptoms entirely, and only on Tuesday added more than 1,500 asymptomatic cases to its total.

Stacks of thousands of urns outside funeral homes in Hubei province have driven public doubt in Beijing’s reporting.

Deborah Birx, the State Department immunologist advising the White House on its response to the outbreak, said Tuesday that China’s public reporting influenced assumptions elsewhere in the world about the nature of the virus.

Coronavirus: Doctor at hospital in China's Hubei province ... source

“The medical community made — interpreted the Chinese data as: This was serious, but smaller than anyone expected,” she said at a news conference on Tuesday. “Because I think probably we were missing a significant amount of the data, now that what we see happened to Italy and see what happened to Spain.”

China is not the only country with suspect public reporting. Western officials have pointed to Iran, Russia, Indonesia and especially North Korea, which has not reported a single case of the disease, as probable under-counts. Others including Saudi Arabia and Egypt may also be playing down their numbers.

U.S. Secretary of State Michael Pompeo has publicly urged China and other nations to be transparent about their outbreaks. He has repeatedly accused China of covering up the extent of the problem and being slow to share information, especially in the weeks after the virus first emerged, and blocking offers of help from American experts.

“This data set matters,” he said at a news conference in Washington on Tuesday. The development of medical therapies and public-health measures to combat the virus “so that we can save lives depends on the ability to have confidence and information about what has actually transpired,” he said.

“I would urge every nation: Do your best to collect the data. Do your best to share that information,” he said. “We’re doing that.”

The outbreak began in China’s Hubei province in late 2019, but the country has publicly reported only about 82,000 cases and 3,300 deaths, according to data compiled by Johns Hopkins University. That compares to more than 189,000 cases and more than 4,000 deaths in the U.S., which has the largest publicly reported outbreak in the world.

Map of sampling sites in the Hubei Province of China. Red ... source

 

Abstract

Background: The COVID-19 outbreak containment strategies in China based on non-pharmaceutical interventions (NPIs) appear to be effective. Quantitative research is still needed however to assess the efficacy of different candidate NPIs and their timings to guide ongoing and future responses to epidemics of this emerging disease across the World. Methods: We built a travel network-based susceptible-exposed-infectious-removed (SEIR) model to simulate the outbreak across cities in mainland China. We used epidemiological parameters estimated for the early stage of outbreak in Wuhan to parameterise the transmission before NPIs were implemented. To quantify the relative effect of various NPIs, daily changes of delay from illness onset to the first reported case in each county were used as a proxy for the improvement of case identification and isolation across the outbreak. Historical and near-real time human movement data, obtained from Baidu location-based service, were used to derive the intensity of travel restrictions and contact reductions across China. The model and outputs were validated using daily reported case numbers, with a series of sensitivity analyses conducted. Results: We estimated that there were a total of 114,325 COVID-19 cases (interquartile range [IQR] 76,776 – 164,576) in mainland China as of February 29, 2020, and these were highly correlated (p<0.001, R2=0.86) with reported incidence. Without NPIs, the number of COVID-19 cases would likely have shown a 67-fold increase (IQR: 44 – 94), with the effectiveness of different interventions varying. The early detection and isolation of cases was estimated to prevent more infections than travel restrictions and contact reductions, but integrated NPIs would achieve the strongest and most rapid effect. If NPIs could have been conducted one week, two weeks, or three weeks earlier in China, cases could have been reduced by 66%, 86%, and 95%, respectively, together with significantly reducing the number of affected areas. However, if NPIs were conducted one week, two weeks, or three weeks later, the number of cases could have shown a 3-fold, 7-fold, and 18-fold increase across China, respectively. Results also suggest that the social distancing intervention should be continued for the next few months in China to prevent case numbers increasing again after travel restrictions were lifted on February 17, 2020. Conclusion: The NPIs deployed in China appear to be effectively containing the COVID-19 outbreak, but the efficacy of the different interventions varied, with the early case detection and contact reduction being the most effective. Moreover, deploying the NPIs early is also important to prevent further spread. Early and integrated NPI strategies should be prepared, adopted and adjusted to minimize health, social and economic impacts in affected regions around the World.

 

FBI Abuse of FISA Much Worse per New Report

FBI problems with FISA warrants extend beyond Russia case, DOJ watchdog warns

The Justice Department’s chief watchdog issued an extraordinary warning Tuesday that the FBI is failing to follow its own rules when pursuing surveillance warrants in sensitive intelligence and terrorism cases, confirming that problems first exposed in the Russia collusion probe extend to other cases.

Among the problems cited was a failure by agents to substantiate allegations submitted to courts, similar to the missteps the FBI made in failing to ensure allegations in the Steele dossier back in 2016 were verified before securing a FISA warrant targeting the Trump campaign and former adviser Carter Page.

The report found that investigators:

  • could not review original Woods Files for four of the 29 selected FISA applications because the FBI has not been able to locate them and, in 3 of these instances, did not know if they ever existed;
  • identified apparent errors or inadequately supported facts in all of the 25 applications we reviewed;
  • identified deficiencies in documentary support and application accuracy;
  • interviewed FBI officials who indicated to us that there were no efforts by the FBI to use existing FBI and National Security Division oversight mechanisms to perform comprehensive, strategic assessments of the efficacy of the Woods Procedures or FISA accuracy.

Sen. Charles Grassley, R-Iowa, a senior member of the Judiciary Committee who played a key role in exposing FISA abuses during the Russia probe, said Horowitz’s memo show the problems first exposed with the faulty Carter Page warrant were “just the tip of the iceberg.”

“Not a single application from the past five years reviewed by the inspector general was up to snuff. That’s alarming and unacceptable,” Grassley said.

“The FBI has an important job to protect our national security, but it does not have carte blanche to routinely erode the liberties of Americans without proper justification. Oversight mechanisms like the Woods Procedures exist for a reason, and if the FBI wants to restore its reputation among the American people, it had better start taking them seriously,” he added.

Sally Moyer not ‘Agent 5’ in IG report on FBI source

The final report just issued in .pdf is found here.

Additionally, NR has this summary in part:

Horowitz’s office said in a report released Tuesday that of the 29 applications — all of which involved U.S. citizens – that were pulled from “8 FBI field offices of varying sizes,” the FBI could not find Woods Files for four of the applications, while the other 25 all had “apparent errors or inadequately supported facts.”

“While our review of these issues and follow-up with case agents is still ongoing—and we have not made materiality judgments for these or other errors or concerns we identified—at this time we have identified an average of about 20 issues per application reviewed, with a high of approximately 65 issues in one application and less than 5 issues in another application,” the report reveals.

The Woods Procedure dictates that the Justice Department verify the accuracy and provide evidentiary support for all facts stated in its FISA application. The FBI is required to share with the FISA Court all relevant information compiled in the Woods File when applying for a surveillance warrant.

“FBI and NSD officials we interviewed indicated to us that there were no efforts by the FBI to use existing FBI and NSD oversight mechanisms to perform comprehensive, strategic assessments of the efficacy of the Woods Procedures or FISA accuracy, to include identifying the need for enhancements to training and improvements in the process, or increased accountability measures,” the report states.

The OIG concludes by recommending that the FBI “systematically and regularly examine the results of past and future accuracy reviews to identify patterns or trends in identified errors” relating to the Woods Procedure, as well as double-checking “that Woods Files exist for every FISA application submitted to the FISC in all pending investigations.”

In a letter acknowledging the audit, FBI Associate Deputy Director Paul Abbate said that the issues “will be addressed” by the Bureau’s already-issued correctives after the Carter Page review, and added that “the FBI fully accepts the two recommendations.”

McCabe admitted in January that the FBI has an “inherent weakness in the process” of obtaining FISA warrants.

China Supplied Faulty Coronavirus Test Kits

Seems to be a systemic problem with China as in 2017, the Chinese Communist Party issued a sizable medical equipment recall for faulty quality. It is unclear just what equipment was included but the CCP said they would reissue equipment under tighter controls. Swell.

China Supplied Faulty Coronavirus Test Kits to Spain, Czech Republic source

Translated from El Pais newspaper:

The much-announced rapid tests for coronaviruses with which the Government wanted to start testing the broader layers of the population to find out what is the real size of the contagion in Spain do not work well. This has been confirmed by several microbiology laboratories of large hospitals in the analyzes that have been made of the kits recently arrived from China. The results of these preliminary tests are discouraging: “They do not detect the positive cases as expected,” says a source who has participated in the tests and who asks for anonymity.

The rapid tests, manufactured by the Chinese company Bioeasy, based in Shenzhen, one of the technological poles of the Asian country, have a sensitivity of 30%, when it should be above 80%, these sources indicate. One of the microbiologists who has analyzed the Chinese test assures: “With that value it does not make sense to use these tests.” The conclusion of the experts who have evaluated these detection kits is that they will have to continue using the current test, the PCR. This has been reported to the Carlos III Health Institute, under the Ministry of Health.

The price of the sale of Chinese medical equipment to Spain was $467 million. In the transaction of medical equipment was 950 ventilators, 5.5 million testing kits and 11 million gloves and 500 million protective face masks. Chinese blamed one of its own companies called Bioesy and declared the company was not licensed. Okay, sure Beijing.

***

From NR:

Up to 80 percent of the 150,000 portable, quick coronavirus test kits China delivered to the Czech Republic earlier this month were faulty, according to local Czech news site Expats.cz. The tests can produce a result in 10 or 15 minutes but are usually less accurate than other tests. Because of the high error rate, the country will continue to rely on conventional laboratory tests, of which they perform about 900 a day.

The country’s Health Ministry paid $546,000 for 100,000 of the test kits, while the Interior Ministry paid for the other 50,000.

Deputy Prime Minister and Interior Minister Jan Hamacek downplayed the discovery that many of the tests were faulty, blaming it on a possible wrong methodology and saying the kits can still be used “when the disease has been around for some time,” or when “someone returns after quarantine after fourteen days.”

“In my opinion, this is not about some scandalous revelation that it is not working,” Hamacek said.

Meanwhile, Spain, which has more than 56,000 infected people and more than 4,000 coronavirus deaths, the second-highest number of fatalities in the world after Italy, found that the rapid coronavirus test kits it purchased from Chinese company Bioeasy only correctly identified 30 percent of virus cases, according to Spanish newspaper El Pais.

The director Spain’s Center for Health Alerts and Emergencies, Fernando Simón, said Spain tested 9,000 of the test kits and will return them based on their high error rate.

Studies performed on the tests which discovered the high error rate caused the Spanish Society of Infectious Diseases and Clinical Microbiology to recommend officially that the tests not be used.

The Chinese embassy in Spain claimed the Bioeasy products are not included in the products China has been supplying to countries where the virus has broken out.

Spain sends back Chinese coronavirus testing kits because they don ... source

Spain has 49,515 confirmed cases and there have been so many deaths in one small town, the officials had to use an ice skating rink to hold the bodies for burial processing.